Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Wednesday, December 22, 2010
Cumberland Says FDA Rejects Liver Drug's New Indication
In March the company had filed a supplementary new drug application for an indication of the drug to treat liver failure caused by factors such as hepatitis B and autoimmune hepatitis.